U.S. markets close in 4 hours 47 minutes
  • S&P 500

    4,239.96
    +15.17 (+0.36%)
     
  • Dow 30

    33,949.07
    +72.10 (+0.21%)
     
  • Nasdaq

    14,187.10
    +45.62 (+0.32%)
     
  • Russell 2000

    2,276.24
    -9.85 (-0.43%)
     
  • Crude Oil

    73.43
    -0.23 (-0.31%)
     
  • Gold

    1,781.00
    -1.90 (-0.11%)
     
  • Silver

    25.90
    -0.13 (-0.50%)
     
  • EUR/USD

    1.1909
    -0.0016 (-0.13%)
     
  • 10-Yr Bond

    1.4800
    -0.0040 (-0.27%)
     
  • GBP/USD

    1.3927
    -0.0006 (-0.04%)
     
  • USD/JPY

    110.7350
    +0.4370 (+0.40%)
     
  • BTC-USD

    30,876.00
    -2,061.00 (-6.26%)
     
  • CMC Crypto 200

    736.71
    -57.61 (-7.25%)
     
  • FTSE 100

    7,083.34
    +21.05 (+0.30%)
     
  • Nikkei 225

    28,884.13
    +873.20 (+3.12%)
     

CLASS ACTION UPDATE for NEPT, KDMN and ACAD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / April 26, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

NEPT Shareholders Click Here: https://www.zlk.com/pslra-1/neptune-wellness-solutions-inc-loss-submission-form?prid=15122&wire=1
KDMN Shareholders Click Here: https://www.zlk.com/pslra-1/kadmon-holdings-inc-loss-submission-form?prid=15122&wire=1
ACAD Shareholders Click Here: https://www.zlk.com/pslra-1/acadia-pharmaceuticals-inc-loss-submission-form?prid=15122&wire=1

* ADDITIONAL INFORMATION BELOW *

Neptune Wellness Solutions Inc. (NASDAQ:NEPT)

NEPT Lawsuit on behalf of: investors who purchased July 24, 2019 - February 16, 2021
Lead Plaintiff Deadline : May 17, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/neptune-wellness-solutions-inc-loss-submission-form?prid=15122&wire=1

According to the filed complaint, during the class period, Neptune Wellness Solutions Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the cost of Neptune's integration of the assets and operations acquired in the SugarLeaf Acquisition would be larger than the Company had acknowledged, placing significant strain on the Company's capital reserves; (ii) accordingly, it was reasonably foreseeable that the company would need to conduct additional stock offerings to raise more capital; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Kadmon Holdings, Inc. (NASDAQ:KDMN)

KDMN Lawsuit on behalf of: investors who purchased October 1, 2020 - March 10, 2021
Lead Plaintiff Deadline : June 2, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/kadmon-holdings-inc-loss-submission-form?prid=15122&wire=1

According to the filed complaint, during the class period, Kadmon Holdings, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the Belumosudil NDA was incomplete and/or deficient; (ii) the additional new data that the Company submitted in support of the Belumosudil NDA in response to an information request from the FDA materially altered the NDA submission; (iii) accordingly, the initial Belumosudil NDA submission lacked the degree of support that the Company had led investors to believe; (iv) accordingly, the FDA was likely to extend the PDUFA target action date to review the Belumosudil NDA; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD)

ACAD Lawsuit on behalf of: investors who purchased June 15, 2020 - April 4, 2021
Lead Plaintiff Deadline : June 18, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/acadia-pharmaceuticals-inc-loss-submission-form?prid=15122&wire=1

According to the filed complaint, during the class period, Acadia Pharmaceuticals Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the materials submitted in support of the pimavanserin sNDA contained statistical and design deficiencies; (ii) accordingly, the pimavanserin sNDA lacked the evidentiary support that the Company had led investors to believe it possessed; (iii) the FDA was unlikely to approve the pimavanserin sNDA in its present form; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/642194/CLASS-ACTION-UPDATE-for-NEPT-KDMN-and-ACAD-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders